Differing postnatal development of the somatostatin- and luliberin- systems in the male and female rat.
By means of light-microscopic immunohistochemistry the perikarya of the luliberin-(LRF-) and somatostatin systems of neonate rats were found to be in differing stages of development. At a time point when the LRF-producing neurons had obviously attained their final shape and size, the somatostatin-immunoreactive perikarya were still in a postnatal phase of maturation. Whereas the number of the latter perikarya increases with advancing age, the number of LRF-immunoreactive perikarya decreases significantly from postnatal day 7 onward. Both peptide-hormone systems do not project concomitantly and to the same extent to their principal neurohemal regions in the organum vasculosum laminae terminalis (OVLT) and the median eminence (ME). In all presently studied stages of development, despite considerable individual variations in one age group, among the components of the LRF-system the OVLT displays a more intense immunoreactivity than the ME. The somatostatin system, however, projects to the OVLT with a conspicuous temporal delay compared to the ME, and, furthermore, in the OVLT the pattern of immunoreactivity characteristic of adult rats is not yet attained at postnatal day 21. Evidence for differences in the immunoreactivity between male and female animals was restricted to the LRF-system. Finally, the results obtained on the stria terminalis speak in favour of the fact that the long-range extrahypothalamic projections of the somatostatin system also undergo postnatal maturation. In the stria terminalis, somatostatin-immunoreactive fibers can be demonstrated initially on postnatal day 7. They attain their full immunoreactivity on postnatal day 21. Furthermore, in the bed nucleus of the stria terminalis an intermittent cytoplasmic immunoreactivity is observed, which is limited to the animals of postnatal day 7 and disappears completely during the further course of development.
D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development*; D007025:Anterior Hypothalamic Nucleus / Q000254:growth & development* / Q000648:ultrastructure; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology*; D006651:Histocytochemistry; D007120:Immunochemistry; D008297:Male; D008473:Median Eminence / Q000254:growth & development* / Q000648:ultrastructure; D009474:Neurons / Q000648:ultrastructure; D009490:Neurosecretory Systems / Q000254:growth & development* / Q000378:metabolism / Q000648:ultrastructure; D010455:Peptides / Q000378:metabolism; D010903:Pituitary Gland, Anterior / Q000254:growth & development / Q000378:metabolism; D051381:Rats / Q000254:growth & development*; D012737:Sex Factors; D013004:Somatostatin / Q000502:physiology*
D010455:Peptides; D007987:Gonadotropin-Releasing Hormone; D013004:Somatostatin